Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Basmisanil Formulations in Healthy Volunteers
NCT02194244Phase 1Completed
- Sponsor
- Roche
- Start
- Aug 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of basmisanil in Down syndrome (4 arms), sponsored by Roche. Primary endpoint: Area Under the Concentration-Time Curve up to 9 weeks. Started Aug 2014; status: completed.
02
Drugs
basmisanil
03
Conditions
Down syndrome
Beyond the preview
Go deeper on NCT02194244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02194244.